BNP Paribas Financial Markets’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
121,494
+26,893
| +28% | +$54.9K | ﹤0.01% | 2898 |
|
|
2025
Q1 | $126K | Buy |
94,601
+19,900
| +27% | +$26.5K | ﹤0.01% | 3129 |
|
|
2024
Q4 | $198K | Buy |
74,701
+15,900
| +27% | +$42.1K | ﹤0.01% | 3036 |
|
|
2024
Q3 | $107K | Buy |
58,801
+7,300
| +14% | +$13.3K | ﹤0.01% | 2718 |
|
|
2024
Q2 | $85.5K | Buy |
51,501
+16,500
| +47% | +$27.4K | ﹤0.01% | 2655 |
|
|
2024
Q1 | $80.1K | Buy |
35,001
+19,100
| +120% | +$43.7K | ﹤0.01% | 2826 |
|
|
2023
Q4 | $31.5K | Buy |
15,901
+9,200
| +137% | +$18.2K | ﹤0.01% | 2910 |
|
|
2023
Q3 | $8.71K | Sell |
6,701
-3,226
| -32% | -$4.19K | ﹤0.01% | 2954 |
|
|
2023
Q2 | $16.1K | Buy |
9,927
+9,422
| +1,866% | +$15.3K | ﹤0.01% | 2981 |
|
|
2023
Q1 | $1.08K | Sell |
505
-1,700
| -77% | -$3.62K | ﹤0.01% | 3049 |
|
|
2022
Q4 | $8.16K | Buy |
2,205
+2,159
| +4,693% | +$7.99K | ﹤0.01% | 2967 |
|
|
2022
Q3 | $34 | Sell |
46
-2,968
| -98% | -$2.19K | ﹤0.01% | 3967 |
|
|
2022
Q2 | $2.34K | Buy |
+3,014
| New | +$2.34K | ﹤0.01% | 3223 |
|
|
2022
Q1 | – | Sell |
-2,326
| Closed | -$18.6K | – | 3638 |
|
|
2021
Q4 | $18.6K | Buy |
+2,326
| New | +$18.6K | ﹤0.01% | 3207 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$2.1K | – | 3448 |
|
|
2020
Q4 | $2.1K | Buy |
+500
| New | +$2.1K | ﹤0.01% | 3336 |
|